|
WO2019134036A1
|
|
Innate targeting of adoptive cellular therapies
|
|
WO2018085937A1
|
|
Managing site specific ibd immunotherapies
|
|
US2018050099A1
|
|
Personalized Site-Specific Immunomodulation
|
|
CA3061077A1
|
|
Therapeutically triggering an innate immune response in a target tissue
|
|
US2015343050A1
|
|
Tissue targeted antigenic activation of the immune response to treat cancers
|
|
CN105816863A
|
|
Immunogenic anti-inflammatory compositions
|
|
CA2997459A1
|
|
Tissue targeted antigenic activation of the immune response to cancers
|
|
AU2005251397A1
|
|
Bacterial compositions for the treatment of cancer
|
